To this point, RBM6-RBM5 chimeric expression was observed in the human breast adenocarcinoma cell line MDA-MB-231, T lymphoblastic leukemia Jurkat cell line and skeletal muscle tumour, all representing malignant cancers. This evidence concerns the gene RBM5 and skeletal muscle neoplasm.